Worse Survival Observed Among Patients Diagnosed with Cancer During the First 2 Years of the COVID-19 Pandemic By Ogkologos - February 16, 2026 237 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the US cohort study Source RELATED ARTICLESMORE FROM AUTHOR Enzalutamide Continues to Provide Substantial Long-Term OS Benefit at 8 Years for Patients with Metastatic Hormone-Sensitive Prostate Cancer Metastatic Breast Cancer: ESMO Living Guideline EMA Recommends Extension of Indications for Datopotamab Deruxtecan MOST POPULAR Finding Hope in the New Year During COVID-19 and Cancer January 6, 2021 Radiation Treatment Delivery Improved Using a Visualization of the Invisible Radiation... January 21, 2021 Aiming to Improve Cancer Prevention, ESMO Calls for Strong Policy Measures... July 20, 2026 Efficacy of Afamitresgene Autoleucel for HLA-A*02-positive and MAGE-A4-positive Synovial Sarcoma Following... April 2, 2024 Load more HOT NEWS Immunotherapy Combination That Targets TIGIT Receptor Shows Promise in Non-Small Cell... Taletrectinib Demonstrates Durable Long-Term Efficacy in Both TKI-naïve and Crizotinib-pretreated Patients... Changes in Metabolism Help Melanomas Spread Encouraging Early Results Seen with Novel MEDI1191 in Advanced Tumours
